Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Dennis Christensen, Karen Smith Korsholm, Peter Andersen & Else Marie Agger. (2011) Cationic liposomes as vaccine adjuvants. Expert Review of Vaccines 10:4, pages 513-521.
Read now
Read now
Malou Henriksen-Lacey, Karen Smith Korsholm, Peter Andersen, Yvonne Perrie & Dennis Christensen. (2011) Liposomal vaccine delivery systems. Expert Opinion on Drug Delivery 8:4, pages 505-519.
Read now
Read now
Steven Dow. (2008) Liposome–nucleic acid immunotherapeutics. Expert Opinion on Drug Delivery 5:1, pages 11-24.
Read now
Read now
Daniel J. Kirby, Ida Rosenkrands, Else M. Agger, Peter Andersen, Allan G. A. Coombes & Yvonne Perrie. (2008) Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres. Journal of Drug Targeting 16:7-8, pages 543-554.
Read now
Read now
Dennis Christensen, Karen S Korsholm, Ida Rosenkrands, Thomas Lindenstrøm, Peter Andersen & Else Marie Agger. (2007) Cationic liposomes as vaccine adjuvants. Expert Review of Vaccines 6:5, pages 785-796.
Read now
Read now
Sarah E McNeil & Yvonne Perrie. (2006) Gene delivery using cationic liposomes. Expert Opinion on Therapeutic Patents 16:10, pages 1371-1382.
Read now
Read now
Articles from other publishers (19)
Ana Maria Carmona-Ribeiro & Yunys Pérez-Betancourt. (2020) Cationic Nanostructures for Vaccines Design. Biomimetics 5:3, pages 32.
Crossref
Crossref
Fujie Zhu, Xiao Liu, Zhenhong Sun, Cuilian Yu, Liping Liu, Shifa Yang, Bing Li, Kai Wei & Ruiliang Zhu. (2016) Immune-Enhancing Effects of Taishan Pinus massoniana Pollen Polysaccharides on DNA Vaccine Expressing Bordetella avium ompA. Frontiers in Microbiology 7.
Crossref
Crossref
Reinier Borrero, María de los A García, Liem Canet, Caridad Zayas, Fátima Reyes, Jorge L Prieto, Juan F Infante, María E Lanio, Ramlah Kadir, Yamilé López, María E Sarmiento, Mohd Nor Norazmi & Armando Acosta. (2013) Evaluation of the humoral immune response and cross reactivity against Mycobacterium tuberculosis of mice immunized with liposomes containing glycolipids of Mycobacterium smegmatis. BMC Immunology 14:S1.
Crossref
Crossref
Yvonne Perrie, Randip Kaur & Malou Henriksen-Lacey. 2013. Fundamentals of Pharmaceutical Nanoscience. Fundamentals of Pharmaceutical Nanoscience
465
491
.
Huaiyu Zhou, Juan Min, Qunli Zhao, Qinmin Gu, Hua Cong, Ying Li & Shenyi He. (2012) Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant. Vaccine 30:10, pages 1800-1806.
Crossref
Crossref
Asim K. Duttaroy. 2012. Phospholipid Technology and Applications. Phospholipid Technology and Applications
153
167
.
Glen Perera & Andreas Bernkop-Schnürch. 2012. Gene Vaccines. Gene Vaccines
109
125
.
Behfar Moghaddam, Sarah E. McNeil, Qinguo Zheng, Afzal R. Mohammed & Yvonne Perrie. (2011) Exploring the Correlation Between Lipid Packaging in Lipoplexes and Their Transfection Efficacy. Pharmaceutics 3:4, pages 848-864.
Crossref
Crossref
Myrra G. Carstens, Marcel G.M. Camps, Malou Henriksen-Lacey, Kees Franken, Tom H.M. Ottenhoff, Yvonne Perrie, Joke A. Bouwstra, Ferry Ossendorp & Wim Jiskoot. (2011) Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines. Vaccine 29:29-30, pages 4761-4770.
Crossref
Crossref
Malou Henriksen-Lacey, Dennis Christensen, Vincent W. Bramwell, Thomas Lindenstrøm, Else Marie Agger, Peter Andersen & Yvonne Perrie. (2010)
Comparison of the Depot Effect and Immunogenicity of Liposomes Based on Dimethyldioctadecylammonium (DDA), 3β-[
N
-(
N
′,
N
′-Dimethylaminoethane)carbomyl] Cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium Propane (DOTAP): Prolonged Liposome Retention Mediates Stronger Th1 Responses
. Molecular Pharmaceutics 8:1, pages 153-161.
Crossref
Crossref
Vincent W Bramwell & Yvonne Perrie. (2006) Particulate delivery systems for vaccines: what can we expect?. Journal of Pharmacy and Pharmacology 58:6, pages 717-728.
Crossref
Crossref
Dania BacardíYalena Amador-Cañizares, Karelia Cosme, Dioslaida Urquiza, José Suárez, Jeny Marante, Ariel Viña, Ariel Vázquez, Joel Concepción, Maylín Pupo, Lizet Aldana, Yordanka Soria, Juan Romero, Roberto Madrigal, Leticia Martínez, Lourdes Hernández, Idania González & Santiago Dueñas-Carrera. (2009) Toxicology and biodistribution study of CIGB-230, a DNA vaccine against hepatitis C virus. Human & Experimental Toxicology 28:8, pages 479-491.
Crossref
Crossref
Rui Chen, Shao-hong Lu, Qun-bo Tong, Di Lou, Dong-yan Shi, Bing-bing Jia, Guo-ping Huang & Jin-fu Wang. (2009) Protective effect of DNA-mediated immunization with liposome-encapsulated GRA4 against infection of Toxoplasma gondii. Journal of Zhejiang University SCIENCE B 10:7, pages 512-521.
Crossref
Crossref
Myrra G. Carstens. (2009) Opportunities and challenges in vaccine delivery. European Journal of Pharmaceutical Sciences 36:4-5, pages 605-608.
Crossref
Crossref
Yvonne Perrie, Afzal R. Mohammed, Daniel J. Kirby, Sarah E. McNeil & Vincent W. Bramwell. (2008) Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens. International Journal of Pharmaceutics 364:2, pages 272-280.
Crossref
Crossref
Julia Myschik, Warren T. McBurney, Thomas Rades & Sarah Hook. (2008) Immunostimulatory lipid implants containing Quil-A and DC-cholesterol. International Journal of Pharmaceutics 363:1-2, pages 91-98.
Crossref
Crossref
Weili Yan, Weihsu Chen & Leaf Huang. (2007) Mechanism of adjuvant activity of cationic liposome: Phosphorylation of a MAP kinase, ERK and induction of chemokines. Molecular Immunology 44:15, pages 3672-3681.
Crossref
Crossref
John R. Greenland & Norman L. Letvin. (2007) Chemical adjuvants for plasmid DNA vaccines. Vaccine 25:19, pages 3731-3741.
Crossref
Crossref
Marie-Claude Gaudreau, Pierre Lacasse & Brian G. Talbot. (2007) Protective immune responses to a multi-gene DNA vaccine against Staphylococcus aureus. Vaccine 25:5, pages 814-824.
Crossref
Crossref